Monitor HCA's 2026 EBITDA performance and quality metrics, as these will determine executive compensation payouts. The board retirement is routine and unlikely to affect governance or strategy.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 26 $525.78entry
- T+1 · 9mo ago +0.21%α +0.66% · $526.87
- T+5 · 9mo ago +1.37%α +2.50% · $532.98
- T+20 · 8mo ago −8.75%α −2.35% · $479.78
- T+60 · 6mo ago −25.34%α −33.09% · $392.56
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HCA Healthcare adopted its 2026 Executive Officer Performance Excellence Program (PEP), establishing cash-based incentive awards for executives tied to EBITDA (80%) and quality metrics (20%). The filing also announced the retirement of board member Robert J. Dennis effective April 23, 2026. No financial results or material operational changes were disclosed.
Key Facts
- HCA adopted the 2026 Executive Officer Performance Excellence Program (PEP) on February 24, 2026
- PEP awards are cash-based and tied to 80% EBITDA targets and 20% quality metrics (infections, complications, care experience)
- Target award opportunities: 175% of base salary for CEO Samuel Hazen, 125% for CFO Michael Marks and COO Jon Foster, 100% for other named executives
- No payment is made for quality metrics if actual EBITDA is below 90% of target
- Board member Robert J. Dennis will retire effective April 23, 2026, after not standing for re-election
Financial Impact
No immediate financial impact disclosed; potential future cash compensation expense tied to 2026 performance
Risk Factors
- Executive compensation could increase significantly if EBITDA and quality targets are exceeded
- No quality payouts if EBITDA falls below 90% of target, creating misalignment risk in challenging financial conditions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-071880 |
| Document: d945112dex101.htm | 0001193125-26-071880 |
| Document: 0001193125-26-071880-index-headers.html | 0001193125-26-071880 |
| Document: 0001193125-26-071880-index.html | 0001193125-26-071880 |
| Document: 0001193125-26-071880.txt | 0001193125-26-071880 |
Track record
19 reports on HCA
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $506.04 Now $511.78 +1.13% settles Feb 9
- Nov 6, 202610d ago SC 13D/A Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $504.89 Now $511.78 +1.36% settles Feb 5
- Nov 5, 202611d ago 8-K Neutral 3/10 Entry $494.99 Now $511.78 +3.39% settles Feb 4
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $507.48 Now $511.78 +0.85% settles Feb 3
- Nov 2, 202614d ago 8-K Neutral 3/10 Entry $462.86 Now $511.78 +10.57% settles Feb 1
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $473.19 Now $511.78 +8.16% settles Jan 28
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $463.22 Now $511.78 +10.48% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers